NDC 59051-9128 - ThyroKare
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59051-9128
- Package NDCs from labels
- 59051-9128-9
- Manufacturer
- Neogen Corporation-Mercer Rd | Peptido GmbH
- Effective date
- 2018-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ThyroKare - Neogen Corporation-Mercer Rd | Peptido GmbH | Neogen Corporation-Mercer Rd | Peptido GmbH | 2018-11-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59051-9128-9 | ThyroKare | 4536 g in 1 PAIL | Powder | 4536 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59051-9128 | THYROKARE (LEVOTHYROXINE SODIUM) POWDER [NEOGEN CORPORATION-MERCER RD] | 1 | 1 package rows | 20181102_f200780c-8532-43e3-bc97-c901ebddb1da.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d6ce9798-7204-41df-9aeb-067000cb0895 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Macleods Pharmaceuticals Limited | b8c20f76-3ee6-4b29-b77f-ed4ad1baaed9 | 2024-03-04 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Synthroid | LEVOTHYROXINE SODIUM | AbbVie Inc. | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 2024-02-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 804d64c9-9804-4d6d-adb2-5036c0be8b5c | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3e77de84-6f59-40ac-a1a4-7bfe30387823 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 89df6a0f-6602-4c22-a052-b565ea8368a7 | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 60a0bc29-4283-4ae9-9173-5caf9266f723 | 2023-11-16 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 970b8456-5b9a-4839-9222-4ec1302266e2 | 2023-11-02 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 59762069-5ea7-43d9-ba5b-8b250767b146 | 2023-09-14 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 51a27110-e787-409b-98ba-c6471d0ad5cf | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Camber Pharmaceuticals, Inc. | b1ba1c7d-371a-4aa8-bee8-dd29b5e7da7e | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2f129a3d-f3e6-45b2-9704-3ad171cbd8a5 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 329b6eb2-4fa3-41f6-a6ff-96d94b7a65bf | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 9d1aaa2d-c8c0-478f-8540-f92f6512cfcb | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | ca197216-83f1-470a-9313-d1b923924661 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 7ceed5ff-fd41-4ebd-ade7-e31b135231c1 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2daab9ce-0570-4fdf-a7bd-01c3178f8cf3 | 2021-03-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2f0657d5-3e5c-4249-bfaa-7f5ef1528672 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOXYL | LEVOTHYROXINE SODIUM | Pfizer Laboratories Div Pfizer Inc | 758588c3-c63e-491b-0aa2-4f50d80cb174 | 2020-12-15 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 388a1f15-8c1c-46a5-997f-7f326f696b59 | 2020-12-04 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.